Study on immune persistence of the CTN-1V strain rabies vaccine in humans
This study is a single-arm, single-center phase IV clinical trial on a rabies vaccine that has been marketed in China. The Vero cells and CTN-1V strain are used in the rabies vaccine product. The purpose of this study was to investigate the safety, immunogenicity and immune persistence of this produ...
المؤلفون الرئيسيون: | , , , , , , , , , , |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Elsevier
2024-03-01
|
سلاسل: | Journal of Virus Eradication |
الموضوعات: | |
الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S2055664024000025 |